Home Infusion Therapy Market Size By Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Indus

Home Infusion Therapy Market is expected to exceed USD 31 billion by 2025. Technological advancements coupled with increasing demand for home infusion therapy will positively drive the market growth.

Some major findings of the home infusion therapy market report include:

The demand for home infusion therapy is increasing across the globe due rising elderly population that are more prone to chronic diseases.
Rising prevalence of hospital acquired infections caused by viral, bacterial and fungal pathogens due to breaches of infection control practices and procedures will stimulate industry growth.
Presence of home healthcare facilities such as home health care agencies, hospice and home care aid organizations as an alternative to hospitals and clinics will fuel industry growth.
Increasing prevalence of chronic diseases such as cancer, diabetes and cardiovascular disorders will majorly impact the home infusion therapy market growth across the forecast timeframe.

Rising prevalence of hospital acquired infections caused by viral, bacterial and fungal pathogens due to breaches of infection control practices and procedures will stimulate the home infusion therapy market growth. Immunocompromised patients, elderly and children are more prone to suffer from hospital acquired infections. Increasing number of hospitalizations has further boosted hospital acquired infections incidence resulting in higher demand for home infusion therapy.

Technological advancements such as development of smart infusion pumps and other therapy devices will boost the home infusion therapy market. Smart infusion pumps have dose error reduction software that enables identification of drug dosages and presents a warning on the user interface screen alerting the clinicians. Hence, such technological innovations will positively drive home infusion therapy market growth across the projected timeframe.

Limited reimbursement scenario related to home infusion therapies will act as a major growth restricting factor. Although Medicare provides reimbursement for home infused therapies, but it offers limited coverage for home infused drugs. Moreover, some drugs are covered only when delivered through infusion pumps, thus limiting market growth.

Infusion pumps segment will reach USD 15.7 billion by 2025. Infusion pumps deliver fluids that include nutrients as per prescribed medications, in patient’s body through controlled amounts. They are extensively used in medical settings such as, hospitals, homecare, and nursing homes. Associated advantages such as capability to deliver fluids in very minor volumes and exactly at automated intervals or programmed rates will positively boost product demand, thus propelling industry growth.

Parenteral nutrition segment is estimated to witness significant growth rate of 10.3% during the projected period. High growth is attributable to significant growth of home healthcare among developed regions of North America and Europe. Moreover, rising geriatric population base across the world that are more prone to chronic disorders have difficulty in taking nutrition via oral route. Therefore, increasing rate of elderly population coupled with rising demand for home healthcare will foster segmental growth.

North America home infusion therapy market held the majority market share of 44.5%, owing to rising prevalence of chronic diseases coupled with increasing number of hospital acquired infections (HAI’s). According to the Centre for Disease Control and Prevention (CDC) in July 2015, around 648,000 individuals in the U.S. acquired infections due to hospital stay. Furthermore, growing infusion therapy providers along with increasing demand for home infusion therapy are the factors propelling industry growth in North America.

The home infusion therapy market is consolidated in nature. High capital investments associated with home infusion therapies will prevent new players from entering the market. CareFusion, ICU Medical, B. Braun, Fresenius Kabi, Baxter, Smiths Medical, Caesarea Medical Electronics, and Terumo are few of the industry players operating in the home infusion therapy market. These companies are investing in the research and development of novel and effective solutions for infusion therapy. Also, the companies are focused on strategic collaborations, acquisition and new product launch to gain major revenue share and strengthen their market position. For instance, in April 2018, Smiths Medical announced the launch of CADD-Solis wireless infusion pump. This new product launch enabled the company to strengthen its product portfolio, thus augmenting its revenue growth.